- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG-NAG-BMA-MAN.2: 9 residues within 4Å:- Chain A: N.200
- Chain D: D.330, Q.391, V.392, N.393, R.394, Y.453, G.454, T.455
6 PLIP interactions:6 interactions with chain D- Hydrogen bonds: D:N.393, D:N.393, D:R.394, D:N.393, D:R.394, D:D.330, D:D.330
- Water bridges: D:N.393, D:Y.453, D:Q.391, D:E.375, D:Q.391, D:Q.391, D:R.394
NAG-NAG-BMA-MAN.3: 8 residues within 4Å:- Chain A: Q.391, V.392, N.393, R.394, Y.453, G.454, T.455
- Chain B: N.200
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:N.393, A:N.393, A:R.394, A:N.393, A:R.394, A:D.330
- Water bridges: A:N.393, A:Y.453, A:Q.391, A:Q.391, A:Q.391, A:Q.391, A:R.394
NAG-NAG-BMA-MAN.5: 9 residues within 4Å:- Chain B: D.330, Q.391, V.392, N.393, R.394, Y.453, G.454, T.455
- Chain C: N.200
6 PLIP interactions:6 interactions with chain B- Hydrogen bonds: B:N.393, B:N.393, B:R.394, B:N.393, B:R.394, B:D.330
- Water bridges: B:N.393, B:Y.453, B:Q.391, B:R.364, B:E.375, B:Q.391, B:Q.391, B:R.394
NAG-NAG-BMA-MAN.7: 8 residues within 4Å:- Chain C: Q.391, V.392, N.393, R.394, Y.453, G.454, T.455
- Chain D: N.200
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:N.393, C:N.393, C:R.394, C:N.393, C:R.394, C:D.330, C:D.330
- Water bridges: C:N.393, C:Y.453, C:Q.391, C:Q.391, C:E.375, C:E.375, C:Q.391, C:Q.391, C:R.394
- 4 x CA: CALCIUM ION(Non-covalent)
CA.8: 5 residues within 4Å:- Chain A: D.293, G.297, D.324, G.345, Q.347
6 PLIP interactions:5 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.293, A:G.297, A:D.324, A:G.345, A:Q.347, H2O.1
CA.10: 5 residues within 4Å:- Chain B: D.293, G.297, D.324, G.345, Q.347
6 PLIP interactions:5 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.293, B:G.297, B:D.324, B:G.345, B:Q.347, H2O.23
CA.13: 6 residues within 4Å:- Chain C: D.293, G.297, D.324, G.345, Q.347, G.348
6 PLIP interactions:5 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.293, C:G.297, C:D.324, C:G.345, C:Q.347, H2O.42
CA.15: 5 residues within 4Å:- Chain D: D.293, G.297, D.324, G.345, Q.347
6 PLIP interactions:5 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.293, D:G.297, D:D.324, D:G.345, D:Q.347, H2O.64
- 4 x ZMR: ZANAMIVIR(Non-covalent)
ZMR.9: 17 residues within 4Å:- Chain A: R.118, E.119, L.134, D.151, R.152, R.156, W.178, I.222, R.224, E.227, A.246, E.276, E.277, R.292, N.294, R.371, Y.406
22 PLIP interactions:22 interactions with chain A- Hydrophobic interactions: A:W.178, A:I.222, A:R.224
- Hydrogen bonds: A:R.152, A:W.178, A:W.178, A:R.224, A:E.277, A:R.292, A:R.292
- Water bridges: A:D.151, A:D.151, A:R.156, A:R.156, A:E.227, A:E.277
- Salt bridges: A:R.118, A:E.119, A:D.151, A:E.227, A:R.292, A:R.371
ZMR.12: 16 residues within 4Å:- Chain B: R.118, E.119, D.151, R.152, R.156, W.178, I.222, R.224, E.227, A.246, E.276, E.277, R.292, N.294, R.371, Y.406
21 PLIP interactions:21 interactions with chain B- Hydrophobic interactions: B:W.178, B:I.222
- Hydrogen bonds: B:R.152, B:W.178, B:W.178, B:R.224, B:E.277, B:R.292, B:R.292
- Water bridges: B:D.151, B:R.156, B:R.224, B:E.227, B:E.277, B:G.348
- Salt bridges: B:R.118, B:E.119, B:D.151, B:E.227, B:R.292, B:R.371
ZMR.14: 16 residues within 4Å:- Chain C: R.118, E.119, D.151, R.152, R.156, W.178, I.222, R.224, E.227, A.246, E.276, E.277, R.292, N.294, R.371, Y.406
20 PLIP interactions:20 interactions with chain C- Hydrophobic interactions: C:W.178, C:I.222
- Hydrogen bonds: C:R.152, C:W.178, C:W.178, C:R.224, C:E.277, C:R.292, C:R.292
- Water bridges: C:D.151, C:R.156, C:R.156, C:E.277, C:R.371
- Salt bridges: C:R.118, C:E.119, C:D.151, C:E.227, C:R.292, C:R.371
ZMR.16: 17 residues within 4Å:- Chain D: R.118, E.119, L.134, D.151, R.152, R.156, W.178, I.222, R.224, E.227, A.246, E.276, E.277, R.292, N.294, R.371, Y.406
23 PLIP interactions:23 interactions with chain D- Hydrophobic interactions: D:W.178, D:I.222, D:R.224
- Hydrogen bonds: D:R.152, D:W.178, D:W.178, D:R.224, D:E.277, D:R.292, D:R.292
- Water bridges: D:D.151, D:D.151, D:D.151, D:R.156, D:R.224, D:E.227, D:E.277
- Salt bridges: D:R.118, D:E.119, D:D.151, D:E.227, D:R.292, D:R.371
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vavricka, C.J. et al., Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. Plos Pathog. (2011)
- Release Date
- 2011-11-16
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.89 Å
- Oligo State
- homo-tetramer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- 4 x CA: CALCIUM ION(Non-covalent)
- 4 x ZMR: ZANAMIVIR(Non-covalent)
- 1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vavricka, C.J. et al., Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. Plos Pathog. (2011)
- Release Date
- 2011-11-16
- Peptides
- Neuraminidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D